RecruitingNot ApplicableNCT06141941
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
Sponsor
Andrea L. Greiner
Enrollment
40 participants
Start Date
Jun 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This study investigates whether using a continuous glucose monitor (CGM) — a small wearable sensor that tracks blood sugar levels in real time — during the hospital stay right after giving birth can reduce dangerous low blood sugar episodes (hypoglycemia) in women with pre-existing type 1 or type 2 diabetes.
**You may be eligible if...**
- You are in your third trimester of pregnancy and admitted to the hospital
- You have type 1 or type 2 diabetes (not gestational diabetes)
- You own a compatible smart device to receive readings from the CGM
**You may NOT be eligible if...**
- You are under 18 years old
- You do not speak English
- You have gestational diabetes (only pre-existing type 1 or type 2 qualifies)
- You have extensive skin conditions that prevent wearing a sensor, or a known allergy to adhesives
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECGM
Continuous glucose monitoring
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06141941